|Articles|July 1, 2004

July 2004 - Part 1
Volume 10
Issue 7 Pt 1

Cost Impacts of Illness on Families and Society

Author(s)David Share, MD, MPH

Download PDF: Cost Impacts of Illness on Families and Society

Articles in this issue

about 22 years ago

Article

Potential Application of the National Kidney Foundation's Chronic Kidney Disease Guidelines in a Managed Care Setting

about 22 years ago

Article

Genetic Testing and Pharmacogenomics: Issues for Determining the Impact to Healthcare Delivery and Costs

about 22 years ago

Article

Plan-Sponsor Savings and Member Experience With Point-of-Service Prescription Step Therapy

about 22 years ago

Article

Medical Management of Osteoporosis

about 22 years ago

Article

Prescribing Proton Pump Inhibitors for Initial Treatment of Acid-related Gastrointestinal Diseases in a Managed Care Population

about 22 years ago

Article

Using Guidelines to Improve Care of Patients With Chronic Kidney Disease

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Cost Impacts of Illness on Families and Society

Articles in this issue

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Trending on AJMC

Medicaid MFN Pricing Could Save $8.6 Billion

CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks

Active US Drug Shortages Rise for Third Straight Quarter

Access Barriers, Not Science, Slow Retina Care: Paul Hahn, MD

Early-Onset CKD Mortality Declines Globally as Incidence Continues to Rise